Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia
<p>Abstract</p> <p>Background</p> <p>Preclinical studies demonstrated that small chain RNA fragments accelerate the recovery of platelets numbers in animals exposed to high doses of chemotherapeutic drugs. There is anecdotal data supporting the same application in human...
Main Authors: | Hall John L, Grutsch James F, Daehler MaryAnn, Levin Robert D, Gupta Digant, Lis Christopher G |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-10-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/565 |
Similar Items
-
Borderline thrombocytopenia or mild idiopathic thrombocytopenic purpura?
by: Jacques Zimmer, et al.
Published: (2006-08-01) -
Validation of actigraphy to assess circadian organization and sleep quality in patients with advanced lung cancer
by: Levin Robert D, et al.
Published: (2011-05-01) -
Detection and dynamics of anti‐platelet antibodies in thrombocytopenic dogs with and without idiopathic immune thrombocytopenia
by: Sarah Shropshire, et al.
Published: (2020-03-01) -
Immune thrombocytopenia is different from thrombotic thrombocytopenic purpura
by: Mafdy N Basta
Published: (2020-01-01) -
Individualized chemotherapy drug dose escalation in dogs with multicentric lymphoma
by: Jacob M. Siewert, et al.
Published: (2023-11-01)